A carregar...

Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia.

Fifty four patients with idiopathic Parkinson's disease receiving levodopa therapy were studied. Thirty three of these patients displayed peak-dose dyskinesia. Neither the duration of Parkinson's disease nor the duration of levodopa therapy discriminated between patients with and patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Horstink, M W, Zijlmans, J C, Pasman, J W, Berger, H J, van't Hof, M A
Formato: Artigo
Idioma:Inglês
Publicado em: 1990
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1014132/
https://ncbi.nlm.nih.gov/pubmed/2324754
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!